Rivaroxaban Dosing for DVT
For acute DVT treatment, rivaroxaban should be dosed at 15 mg orally twice daily for the first 21 days, followed by 20 mg once daily thereafter. 1, 2, 3, 4
Initial Treatment Phase (Days 1-21)
- 15 mg twice daily with food for 21 days
- This higher initial dose provides intensive anticoagulation during the acute thrombotic phase
- Both doses should be taken with food to optimize absorption 4
Maintenance Phase (Day 22 onwards)
- 20 mg once daily with food
- Continue for minimum 3 months, with duration determined by thrombotic risk factors
- After completing ≥6 months of treatment, consider dose reduction to 10 mg once daily for extended secondary prevention in select patients 1, 5
Key Dosing Considerations
Renal impairment:
- CrCl 30-50 mL/min: Use standard dosing initially, but monitor closely 6
- CrCl 15-29 mL/min: Use with extreme caution; limited clinical data 6
- CrCl <15 mL/min: Contraindicated 4
Cancer-associated DVT:
- Same dosing regimen (15 mg BID × 21 days, then 20 mg daily) 2, 3, 7
- LMWH remains preferred for first 6 months in cancer patients with proximal DVT, but rivaroxaban is an acceptable alternative for those who refuse or cannot tolerate injections 2, 3, 7
Administration tips:
- Tablets can be crushed and mixed with applesauce if swallowing difficulty exists 4
- If dose missed during BID phase: take immediately if >6 hours until next dose; skip if <6 hours remaining
- If dose missed during once-daily phase: take immediately same day; skip if next day 4
Duration of Treatment
Provoked DVT (major transient risk factor): 3 months, then stop 5
Unprovoked DVT or persistent risk factors: Extended therapy recommended
- Continue 20 mg daily indefinitely with annual reassessment 5
- After 6 months, may reduce to 10 mg daily for secondary prevention (lower bleeding risk while maintaining efficacy) 8, 5
Common Pitfalls
The most critical error is premature discontinuation of the higher 15 mg BID dose before completing 21 days—this risks inadequate initial anticoagulation during the highest-risk period for clot propagation 4. Another common mistake is forgetting that rivaroxaban requires food intake with each dose to ensure adequate bioavailability, particularly the 15 mg and 20 mg tablets 4.
Do not use reduced-dose rivaroxaban (10 mg daily) during initial treatment—this dose is only validated for extended secondary prevention after completing standard treatment duration 5.